Recombinant Human LASS2 Protein(HEK293)，His

LASS2, or "Lipid-associated synthase 2," is a member of the LASS family, which plays a significant role in the biosynthesis of sphingolipids, critical components of cellular membranes that influence various biological processes. Research into LASS2 has gained momentum due to its potential implications in cancer biology and neurodegenerative diseases, where altered sphingolipid metabolism can contribute to disease progression. Initial studies suggested that LASS2 is involved in regulating apoptosis and cellular signaling pathways by modulating sphingolipid levels. Furthermore, its expression patterns are often altered in various cancer types, indicating its potential as a biomarker for tumor progression and as a therapeutic target. The recombinant expression of LASS2 permits detailed studies on its enzymatic properties and interactions with other cellular components, thereby enhancing our understanding of its biological functions. In light of its role in critical physiological and pathological processes, the investigation of LASS2 as a recombinant protein not only contributes to basic science but also holds promise for developing novel therapeutic strategies aimed at manipulating sphingolipid metabolism in disease contexts. Thus, ongoing research seeks to elucidate the precise mechanisms by which LASS2 operates and its influence on cellular homeostasis and disease states, paving the way for potential clinical applications.